LAB icon

Standard BioTools
LAB

Overview Fund Activity

86 hedge funds and large institutions have $70.2M invested in Standard BioTools in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 28 reducing their positions, and 40 closing their positions.

Holders
86
Holders Change
-23
Holders Change %
-21.1%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
20
Reduced
28
Closed
40
Calls
$109K
Puts
$352K
Net Calls
-$243K
Net Calls Change
+$420K

Top Buyers

1
RCM
1
RA Capital Management
Massachusetts
$3.18M
2
Balyasny Asset Management
2
Balyasny Asset Management
Illinois
$1.82M
3
Millennium Management
3
Millennium Management
New York
$2.17M
4
E
4
Ergoteles
New York
$557K
5
JCP
5
Jennifer C. Price
$392K

Top Sellers

1
BlackRock
1
BlackRock
New York
$3.23M
2
Nuveen Asset Management
2
Nuveen Asset Management
Illinois
$0
3
PHS
3
PFM Health Sciences
California
$0
4
State Street
4
State Street
Massachusetts
$536K
5
UBS Group
5
UBS Group
Switzerland
$47K
Name Market Value Shares Shares
Change 		Shares
Change %
CFGS
126
Concourse Financial Group Securities
Alabama
– – – –
HT
127
HAP Trading
New York
– – – –
WAM
128
Wolverine Asset Management
Illinois
– – – –
HGWM
129
Harvest Group Wealth Management
Massachusetts
$0 145 +145 New
2 3 4 5
6